Surgalign Holdings, Inc. (SRGA): Price and Financial Metrics

Surgalign Holdings, Inc. (SRGA): $0.18

0.09 (-32.98%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

SRGA Price/Volume Stats

Current price $0.18 52-week high $6.77
Prev. close $0.27 52-week low $0.17
Day low $0.18 Volume 8,716,700
Day high $0.24 Avg. volume 1,437,152
50-day MA $0.87 Dividend yield N/A
200-day MA $1.94 Market Cap 1.69M

SRGA Stock Price Chart Interactive Chart >


Surgalign Holdings, Inc. (SRGA) Company Bio


Surgalign Holdings, Inc. operates as a holding company. The Company, through its subsidiaries, provides medical technology solutions with focus on spine surgery and elevating clinical outcomes. Surgalign Holdings serves customers worldwide.


SRGA Latest News Stream


Event/Time News Detail
Loading, please wait...

SRGA Latest Social Stream


Loading social stream, please wait...

View Full SRGA Social Stream

Latest SRGA News From Around the Web

Below are the latest news stories about SURGALIGN HOLDINGS INC that investors may wish to consider to help them evaluate SRGA as an investment opportunity.

Surgalign to Participate at ISASS 2023 – 23rd Annual Conference Sponsored by the International Society for the Advancement of Spine Surgery and Medical Education Resources

Company to showcase its upgraded HOLO Portal™ Surgical Guidance System and key products in its hardware spine and biologics portfolio DEERFIELD, Ill., May 23, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, announced today that it will be exhibiting at ISASS 2023 – the 23rd Annual Conference – sponsored by the International Society for Spine Surgery (“ISASS”

Yahoo | May 23, 2023

Surgalign Announces First Quarter 2023 Results and Provides Update on its Business Operations

DEERFIELD, Ill., May 11, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced financial results for its 2023 first quarter ended March 31, 2023. 2023 First Quarter and Subsequent Corporate Highlights: Launch of HOLO™ AI Insights for Spine Imaging; collaboration with Dr. Alexander Vaccaro, Dr. Pierce Nunley and Spine Institute of Louisiana, and le

Yahoo | May 11, 2023

Surgalign Announces Release of HOLO™ AI Insights for Neurovascular Research

New HOLO AI Insights application aims to advance research of neuroanatomy utilizing artificial intelligenceDEERFIELD, Ill., May 08, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, is proud to announce today, the release of HOLO™ AI Insights for use in neurovascular research. HOLO AI Insights, initially launched in March 2023 for spine imaging, enables custom

Yahoo | May 8, 2023

Surgalign Schedules First Quarter 2023 Earnings Release for May 11, 2023

DEERFIELD, Ill., May 04, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced its plans to release financial results for its first quarter 2023 after the close of trading on May 11, 2023. Surgalign will host a conference call and audio webcast at 4:30 p.m. ET the same day. The conference call can be accessed by dialing (888) 437-3179 (U.S.) or 862

Yahoo | May 4, 2023

Surgalign To Collaborate with Dr. Alexander Vaccaro and Dr. Pierce Nunley to Advance HOLO™ AI Insights and its Artificial Intelligence Technologies

DEERFIELD, Ill., May 03, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, is pleased to announce new collaborative alliances with Dr. Pierce Nunley and the Spine Institute of Louisiana, a prestigious medical facility and one of the top 20 patient-rated U.S. hospitals for best overall care, and Dr. Alexander Vaccaro, an advisor to Surgalign and one of the top-

Yahoo | May 3, 2023

Read More 'SRGA' Stories Here

SRGA Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year -79.61%
3-year -99.64%
5-year -99.87%
YTD N/A
2023 0.00%
2022 -90.74%
2021 -67.29%
2020 -20.07%
2019 -25.95%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!